These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diversion of prescription drugs to the black market: what the states are doing to curb the tide. Forgione DA; Neuenschwander P; Vermeer TE J Health Care Finance; 2001; 27(4):65-78. PubMed ID: 11434714 [TBL] [Abstract][Full Text] [Related]
3. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule. Drug Enforcement Administration (DEA), Justice Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789 [TBL] [Abstract][Full Text] [Related]
4. Resting assured: risk management in the prescription of controlled substances. Longo LP WMJ; 1999; 98(1):23-9. PubMed ID: 10050150 [No Abstract] [Full Text] [Related]
5. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. Joranson DE NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529 [No Abstract] [Full Text] [Related]
6. Va. doctors to report controlled substances. Program targets drugs with high potential for abuse, e.g., oxycontin, percocet. Lubell J Mod Healthc; 2006 Jun; 36(26):32. PubMed ID: 16841650 [No Abstract] [Full Text] [Related]
7. Doctors--the duped drug suppliers? Hunziker C Minn Med; 1982 Jul; 65(7):425. PubMed ID: 7110110 [No Abstract] [Full Text] [Related]
13. Regulatory controversy surrounding ipecac use and misuse. Brushwood DB; Tietze KJ Am J Hosp Pharm; 1986 Jan; 43(1):157-61. PubMed ID: 2869686 [No Abstract] [Full Text] [Related]
14. The Controlled Dangerous Substances Act of 1969. Sonnenreich MR Bull Parenter Drug Assoc; 1970; 24(1):14-22. PubMed ID: 5461193 [No Abstract] [Full Text] [Related]
15. Excessive dispensing of controlled substances: a legal perspective. Morgan WR Ala Med; 1985 Feb; 54(8):13-7. PubMed ID: 3976450 [No Abstract] [Full Text] [Related]
16. Issuance of multiple prescriptions for schedule II controlled substances. Final rule. Drug Enforcement Administration (DEA), Department of Justice Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486 [TBL] [Abstract][Full Text] [Related]
17. Paregoric on prescription. Tice LF Am J Pharm Sci Support Public Health; 1972; 144(2):39-40. PubMed ID: 5068202 [No Abstract] [Full Text] [Related]
18. Prescription data processing--its role in the control of drug abuse. Maronde RF; Seibert S; Katzoff J; Silverman M Calif Med; 1972 Sep; 117(3):22-8. PubMed ID: 5070695 [TBL] [Abstract][Full Text] [Related]
19. [The physician and drugs]. Uvnäs B Lakartidningen; 1979 Dec; 76(50):4611-4. PubMed ID: 575181 [No Abstract] [Full Text] [Related]
20. PADS approach to preventing prescription drug diversion. Ambre JJ NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524 [No Abstract] [Full Text] [Related] [Next] [New Search]